tiprankstipranks
Advertisement
Advertisement

PCRX Stock Latest News

Analyst Initiates Buy on Pacira, Citing Durable Exparel Growth and Pipeline Upside with $30 Price Target
RatingsAnalyst Initiates Buy on Pacira, Citing Durable Exparel Growth and Pipeline Upside with $30 Price Target
9d ago
PCRX
Pacira reinstated with a Buy at Truist
PremiumThe Fly
Pacira reinstated with a Buy at Truist
9d ago
PCRX
Pacira Earnings Call: Growth, Margins and Pipeline
PremiumCompany Announcements
Pacira Earnings Call: Growth, Margins and Pipeline
20d ago
PCRX
Pacira price target raised to $25 from $24 at RBC Capital
PremiumThe Fly
Pacira price target raised to $25 from $24 at RBC Capital
21d ago
PCRX
Pacira cuts FY26 revenue view to $735M-$760M from $745M-$770M,
PremiumThe Fly
Pacira cuts FY26 revenue view to $735M-$760M from $745M-$770M,
21d ago
PCRX
Pacira reports Q2 EPS 73c, consensus 65c
PremiumThe FlyPacira reports Q2 EPS 73c, consensus 65c
22d ago
PCRX
PCRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PCRX Earnings this Week: How Will it Perform?
24d ago
PCRX
Pacira Therapeutics: PCRX-201 Progress and Key ASCEND Catalysts Support Buy Rating; $32 Price Target Reaffirmed
Premium
Ratings
Pacira Therapeutics: PCRX-201 Progress and Key ASCEND Catalysts Support Buy Rating; $32 Price Target Reaffirmed
30d ago
PCRX
Pacira transitions PCRX-201 to a U.S.-based manufacturing process
PremiumThe Fly
Pacira transitions PCRX-201 to a U.S.-based manufacturing process
30d ago
PCRX
Pacira announces UnitedHealth provides separate reimbursement for Exparel
PremiumThe Fly
Pacira announces UnitedHealth provides separate reimbursement for Exparel
2M ago
UNH
PCRX
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
PremiumRatings
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
2M ago
PCRX
Pacira BioSciences Divests CryoTech to Zimmer Biomet
PremiumCompany Announcements
Pacira BioSciences Divests CryoTech to Zimmer Biomet
2M ago
8K
PCRX
Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront
PremiumThe FlyPacira Zimmer to divest iovera degrees to Biomet for $70M upfront
2M ago
ZBH
PCRX
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
Premium
Company Announcements
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
3M ago
8K
PCRX
Glass Lewis recommends shareholders vote for Pacira director nominees
Premium
The Fly
Glass Lewis recommends shareholders vote for Pacira director nominees
3M ago
PCRX
Pacira study shows Exparel reduces opioid use and costs
PremiumThe Fly
Pacira study shows Exparel reduces opioid use and costs
3M ago
PCRX
Pacira issues statement on DOMA’s ‘misleading’ statements
PremiumThe Fly
Pacira issues statement on DOMA’s ‘misleading’ statements
3M ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
3M ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
3M ago
PCRX
Pacira Earnings Call Highlights Growth, Pipeline Momentum
PremiumCompany AnnouncementsPacira Earnings Call Highlights Growth, Pipeline Momentum
4M ago
PCRX
Pacira price target raised to $32 from $30 at Needham
Premium
The Fly
Pacira price target raised to $32 from $30 at Needham
4M ago
PCRX
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
Premium
AI Analyst Ratings
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
4M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >